Lack of Susceptibility of Bicyclic Nucleoside Analogs, Highly Potent Inhibitors of Varicella-Zoster Virus, to the Catabolic Action of Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase-Reference-Cited by-同舟云学术

Lack of Susceptibility of Bicyclic Nucleoside Analogs, Highly Potent Inhibitors of Varicella-Zoster Virus, to the Catabolic Action of Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase

Published:2002-05-01 Issue:5 Volume:61 Page:1140-1145
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Balzarini Jan,Sienaert Rebecca,Liekens Sandra,Van Kuilenburg André,Carangio Antonella,Esnouf Robert,De Clercq Erik,McGuigan Chris

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference23 articles.

1. Balzarini J and McGuigan C (2002a) Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication. J Antimicrob Chemother, in press.

2. Balzarini J and McGuigan C (2002b) Chemotherapy of varicella-zoster virus (VZV) by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides. Biochim Biophys Acta, in press.

3. The antiviral spectrum of (E)-5-(2-bromovinyl)-2 '-deoxyuridine

4. De Clercq E (1997) Virus replication: target functions and events for virus-specific inhibitors. in Antiviral Agents and Human Viral Diseases, eds Galasso GJ Whitley RJ Merigan TC (Lippincott-Raven Publishers, Philadelphia), 4th ed, pp 1–44.

5. De Clercq E (2001) Antiviral activity of nucleoside analogues: the BVDU connection. in Recent Advances in Nucleosides: Chemistry and Chemotherapy, ed Chu D (Elsevier Science B. V. New York) , in press.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis?;Viruses;2022-04-07

2. Advances and Perspectives in the Management of Varicella-Zoster Virus Infections;Molecules;2021-02-20

3. Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients;Expert Review of Anti-infective Therapy;2016-12-12

4. Advances in the Treatment of Varicella-Zoster Virus Infections;Antiviral Agents;2013

5. Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET;Nuclear Medicine and Biology;2012-11